XML 12 R5.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Private Placement
Common Stock
Common Stock
Private Placement
Additional Paid-In Capital
Additional Paid-In Capital
Private Placement
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning Balance at Dec. 31, 2023 $ 121,195   $ 23   $ 237,675   $ (83) $ (116,420)
Beginning Balance, Shares at Dec. 31, 2023     22,522,644          
Exercise of common stock options 79       79      
Exercise of common stock options, Shares     20,277          
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for tax (166)       (166)      
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for tax, Shares     94,618          
Stock-based compensation expense 3,344       3,344      
Unrealized gain (loss) on available-for-sale investments, net of tax 13           13  
Net loss (16,486)             (16,486)
Ending Balance at Mar. 31, 2024 107,979   $ 23   240,932   (70) (132,906)
Ending Balance, Shares at Mar. 31, 2024     22,637,539          
Beginning Balance at Dec. 31, 2023 121,195   $ 23   237,675   (83) (116,420)
Beginning Balance, Shares at Dec. 31, 2023     22,522,644          
Unrealized gain (loss) on available-for-sale investments, net of tax 865              
Net loss (57,725)              
Ending Balance at Sep. 30, 2024 196,892   $ 31   370,224   782 (174,145)
Ending Balance, Shares at Sep. 30, 2024     31,130,892          
Beginning Balance at Mar. 31, 2024 107,979   $ 23   240,932   (70) (132,906)
Beginning Balance, Shares at Mar. 31, 2024     22,637,539          
Issuance of common stock in private placement, net of issuance costs   $ 66,637   $ 8   $ 66,629    
Issuance of common stock in private placement, net of issuance costs, Shares       8,235,000        
Issuance of pre-funded warrants in private placement, net of issuance costs 57,122       57,122      
Exercise of common stock options 11       11      
Exercise of common stock options, Shares     10,598          
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for tax (510)       (510)      
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for tax, Shares     83,118          
Stock-based compensation expense 3,566       3,566      
Unrealized gain (loss) on available-for-sale investments, net of tax 51           51  
Net loss (18,798)             (18,798)
Ending Balance at Jun. 30, 2024 216,058   $ 31   367,750   (19) (151,704)
Ending Balance, Shares at Jun. 30, 2024     30,966,255          
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for tax (1,197)       (1,197)      
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for tax, Shares     164,637          
Stock-based compensation expense 3,671       3,671      
Unrealized gain (loss) on available-for-sale investments, net of tax 801           801  
Net loss (22,441)             (22,441)
Ending Balance at Sep. 30, 2024 196,892   $ 31   370,224   782 (174,145)
Ending Balance, Shares at Sep. 30, 2024     31,130,892          
Beginning Balance at Dec. 31, 2024 176,786   $ 31   373,284   447 (196,976)
Beginning Balance, Shares at Dec. 31, 2024     31,231,264          
Exercise of common stock options 1       1      
Exercise of common stock options, Shares     225          
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for tax (344)       (344)      
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for tax, Shares     120,578          
Stock-based compensation expense 3,791       3,791      
Unrealized gain (loss) on available-for-sale investments, net of tax (164)           (164)  
Net loss (19,680)             (19,680)
Ending Balance at Mar. 31, 2025 160,390   $ 31   376,732   283 (216,656)
Ending Balance, Shares at Mar. 31, 2025     31,352,067          
Beginning Balance at Dec. 31, 2024 $ 176,786   $ 31   373,284   447 (196,976)
Beginning Balance, Shares at Dec. 31, 2024     31,231,264          
Exercise of common stock options, Shares 225              
Unrealized gain (loss) on available-for-sale investments, net of tax $ (335)              
Net loss (58,920)              
Ending Balance at Sep. 30, 2025 128,603   $ 31   384,356   112 (255,896)
Ending Balance, Shares at Sep. 30, 2025     31,549,770          
Beginning Balance at Mar. 31, 2025 160,390   $ 31   376,732   283 (216,656)
Beginning Balance, Shares at Mar. 31, 2025     31,352,067          
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for tax (97)       (97)      
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for tax, Shares     97,677          
Stock-based compensation expense 3,927       3,927      
Unrealized gain (loss) on available-for-sale investments, net of tax (177)           (177)  
Net loss (21,006)             (21,006)
Ending Balance at Jun. 30, 2025 143,037   $ 31   380,562   106 (237,662)
Ending Balance, Shares at Jun. 30, 2025     31,449,744          
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for tax (117)       (117)      
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for tax, Shares     100,026          
Stock-based compensation expense 3,911       3,911      
Unrealized gain (loss) on available-for-sale investments, net of tax 6           6  
Net loss (18,234)             (18,234)
Ending Balance at Sep. 30, 2025 $ 128,603   $ 31   $ 384,356   $ 112 $ (255,896)
Ending Balance, Shares at Sep. 30, 2025     31,549,770